Pancreatic cancer: The Lancet: January 24, 2017
The Lancet in conversation with - Un podcast de The Lancet Group - Les vendredis
Catégories:
John Neoptolomos discusses the ESPAC-4 trial, investigating a chemotherapy drug combination for patients with pancreatic cancer.Continue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv
